ABSTRACT
Objectives In the emergency department (ED), high blood pressure (BP) is commonly observed but mostly used to evaluate patients’ health in the short-term. We aimed to study whether ED-measured BP is associated with incident atherosclerotic cardiovascular disease (ASCVD), myocardial infarction (MI), or stroke in long-term, and to estimate the number needed to screen (NNS) to prevent ASCVD.
Design Electronic Health Records (EHR) and national register-based cohort study. The association between BP and incident ASCVD was studied with Cox-regression.
Setting Two university hospital emergency departments in Sweden.
Data sources BP data were obtained from EDs EHR, and outcome information was acquired through the Swedish National Patient Register for all participants.
Participants All patients ≥18 years old who visited the EDs between 2010 to 2016, with an obtained BP (n=300,193).
Main outcome measures Incident ASCVD, MI, and stroke during follow-up.
Results The subjects were followed for a median of 42 months. 8,999 incident ASCVD events occurred (MI: 4,847, stroke: 6,661). Both diastolic and systolic BP (SBP) was associated with incident ASCVD, MI, and stroke with a progressively increased risk for SBP within hypertension grade 1 (HR 1.15, 95% CI 1.06 to 1.24), 2 (HR 1.35, 95% CI 1.25 to 1.47), and 3 (HR 1.63, 95% CI 1.49 to 1.77). The six-year cumulative incidence of ASCVD was 12% for patients with SBP ≥180 mmHg compared to 2% for normal levels. To prevent one ASCVD event during the median follow-up, NNS was estimated to 151, whereas NNT to 71.
Conclusions BP in the ED is associated with incident ASCVD, MI, and stroke. High BP recordings in EDs should not be disregarded as isolated events, but an opportunity to detect and improve treatment of hypertension. ED-measured BP provides an important and under-used tool with great potential to reduce morbidity and mortality associated with hypertension.
Competing Interest Statement
The authors have declared no competing interest.
Clinical Trial
NCT03954119
Funding Statement
The authors received no financial support for the study, authorship, and publication of this report.
Author Declarations
All relevant ethical guidelines have been followed and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Not Applicable
Any clinical trials involved have been registered with an ICMJE-approved registry such as ClinicalTrials.gov and the trial ID is included in the manuscript.
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant Equator, ICMJE or other checklist(s) as supplementary files, if applicable.
Yes
Footnotes
Trial registration no: ClinicalTrials.gov NCT03954119
Declaration of interest: The authors declare no conflict of interest.
Source of funding: The authors received no financial support for the study, authorship, and publication of this report.
Ethics committee approval: This study has been approved by the Regional Ethical Review Board in Stockholm. Ethical review number 2016/888-31.
Data Availability
No additional data are available.